Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • china

    Tag: china

    You Searched For "china"
    Drugmakers including Novartis, Roche slash prices by 61pc in China to get on reimbursement list

    Drugmakers including Novartis, Roche slash prices by 61pc in China to get on reimbursement list

    Medical Dialogues Bureau29 Nov 2019 3:45 AM GMT
    Seventy new drugs such as Roche's breast cancer treatment Pertuzumab, sold under the trade name Perjeta, Novartis's dermatitis treatment Omalizumab,...
    Penalty levied by SEBI on Jubilant Life Sciences reduced to Rs 5 lakh

    Penalty levied by SEBI on Jubilant Life Sciences reduced to Rs 5 lakh

    Medical Dialogues Bureau8 Nov 2019 4:00 AM GMT
    "We have found that the appellant in... Jubilant Life Sciences would be liable for a penalty only on one count i.e. for non-disclosure of the China...
    Centre ask States not to partner with Philip Morris-led anti-smoking group

    Centre ask States not to partner with Philip Morris-led anti-smoking group

    Medical Dialogues Bureau2 July 2019 3:45 AM GMT
    India's federal health ministry has sent a letter, dated June 24, to chief secretaries of all states, saying they should not partner with FSFW and...
    GSK sells 6 brands including Savlon antiseptic cream to Stada Pharma

    GSK sells 6 brands including Savlon antiseptic cream to Stada Pharma

    Medical Dialogues Bureau8 Jun 2019 4:30 AM GMT
    The price tag for the mainly Europe-focused brand portfolio, which includes itch relief cream Eurax, antiseptic cream Savlon and Tixylix cough...
    Dr Reddy

    Dr Reddy's Laboratories in process to seek permission for launch of 70 products in China

    Farhat Nasim3 Jun 2019 5:30 AM GMT
    Dr Reddy's Chief Operations Officer, Erez Israeli in a recent earnings call said the drug-maker is in the process of seeking necessary approvals from...
    China war on healthcare costs lure Indian drugmaker Sun Pharma: Report

    China war on healthcare costs lure Indian drugmaker Sun Pharma: Report

    Medical Dialogues Bureau6 May 2019 3:45 AM GMT
    China has rolled out an ambitious multi-city bulk procurement program that's driving down prices and providing an opening for Indian manufacturers...
    Tencent-backed China online healthcare venture raises $250 million

    Tencent-backed China online healthcare venture raises $250 million

    Garima25 April 2019 5:37 AM GMT
    BEIJING: China's Tencent Trusted Doctor, a venture backed by tech giant Tencent Holdings, said it has raised $250 million in a fundraising round, as...
    Pfizer, GSK consumer healthcare venture to focus on China, US market

    Pfizer, GSK consumer healthcare venture to focus on China, US market

    Farhat Nasim7 April 2019 3:44 AM GMT
    LONDON: The United States and China will be key focuses for the consumer healthcare venture being formed by GlaxoSmithKline and Pfizer, as the...
    China vaccine scandal ripples through domestic market, threatens global push

    China vaccine scandal ripples through domestic market, threatens global push

    Ruby Khatun Khatun24 July 2018 4:15 AM GMT
    SHANGHAI: A vaccine scandal in China, which has hit a nerve in the country and prompted quick reactions from leaders in Beijing, is sending ripples...
    Over 75 percent of Indian drug import comes from China says pharma body IPCA

    Over 75 percent of Indian drug import comes from China says pharma body IPCA

    Ruby Khatun Khatun21 Dec 2017 4:00 AM GMT
    New Delhi: An overwhelming dependence on drug imports and related raw materials from China could prove harmful for the health sector in India in the...
    China accounts for 66 percent of India

    China accounts for 66 percent of India's bulk drug imports in FY'17

    Ruby Khatun Khatun20 Dec 2017 4:45 AM GMT
    New Delhi: India's bulk drug imports from top five countries stood at Rs 18,372.54 crore in 2016-17 with China accounting for 66 percent, Parliament...
    AstraZeneca steps up China push with new drug joint venture

    AstraZeneca steps up China push with new drug joint venture

    Ruby Khatun Khatun28 Nov 2017 8:20 AM GMT
    LONDON: Drugmaker AstraZeneca plans to turbo-charge its already substantial Chinese business through a new drug development joint venture with a...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    X